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Abstract  
Background. Laryngeal squamous cell carcinoma (SCC) accounts for 1.9% of cancers 
worldwide. Most of these are diagnosed in the early stages (T1-T2, N0). For these, a 
larynx preserving/conserving option is preferable. Beyond transoral laser microsurgery 
(TLM), open partial horizontal laryngectomy (OPHL) is a function-sparing surgical 
technique used to treat laryngeal SCC. 
Methods. We retrospectively analyzed the clinical outcomes of 216 patients who 
underwent OPHL for glottic cT2 laryngeal cancer. 
Results. Five-year overall survival, disease-specific survival, locoregional control, local 
control, laryngeal function preservation, and laryngectomy-free survival rates were 93.1%, 
98.0%, 97.1%, 97.5%, 97.8% and 98.5%, respectively. Disease controls were significantly 
affected by previous treatment and type of surgery employed.  
Conclusions. Although TLM for cT2 laryngeal cancer with unimpaired vocal cord mobility 
still represents a sound option, OPHL offers higher local control and laryngeal preservation 
rates for selected patients with impaired mobility of vocal cords combined with involvement 
of the paraglottic space. 
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Introduction 
Laryngeal squamous cell carcinoma (SCC) accounts for 1.9% of cancers worldwide. Most 
of these are glottic (51%) of which a great many (up to 60%) are diagnosed in the early 
stages (T1-T2, N0, M0) as a result of noticeable voice changes that underlie lesions in true 
vocal cords.2-4 For these locally spread laryngeal tumors, a laryngeal function preserving 
option is preferable. As a consequence, the National Comprehensive Cancer Network 
Guidelines recommend the use of either radiotherapy or partial laryngectomy. However, 
Misono et al. recently highlighted greater overall survival and disease-specific survival in 
patients whose treatment included local surgery with respect to those who received 
radiotherapy alone. In particular, the surgical option includes either open neck partial 
laryngectomy and/or transoral laser microsurgery (TLM). The greater part of the former, 
especially in Europe, is represented by open partial horizontal laryngectomy (OPHL),5 
whereas the latter is usually performed by carbon dioxide laser.6 The choice between an 
open neck or transoral approach is very challenging because of the extreme heterogeneity 
of the lesions and the range of patient-specific variables. 
OPHL is able to partially spare laryngeal function without compromising locoregional 
control8, 9 reaching a good compromise between oncological radicality and functional 
outcome. To standardize the procedure, the European Laryngological Society recently 
proposed a classification of the more commonly adopted OPHL according to extent of 
resection (Type I – supraglottic, Type II – supracricoid, and Type III – supratracheal). 
On the other hand, the advantages of TLM in terms of laryngeal preservation rate and 
early and faster recovery of laryngeal functions have already been reported, as well as the 
negative impact on local control for T3 lesions extending laterally to the thyroarytenoid 
(TA) muscle, with involvement of the paraglottic space (PGS).7, 11-14  
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The heterogeneity in terms of local extent and prognosis of glottic cT2 tumors is well 
known. In particular, impaired vocal cord mobility remains a crucial issue in therapeutic 
planning. Even though accurately performed by new technologies, endoscopic evaluation 
is subjective and debated among specialists when distinguishing the different causes of 
vocal cord impairment such as bulky tumor, vocal muscle infiltration, PGS involvement, 
and crico-arytenoid joint invasion. Moreover, early assessment of PGS involvement 
represents another hot topic in the staging of glottic cancer, even with the most 
sophisticated imaging studies. 
Therefore, when comparing clinical and pathological staging, according to the UICC/AJCC 
classification, a significant number of cases show an upstaging of the primary tumor from 
cT2 to pT3, resulting in false negatives at preoperative imaging. In light of this, in 2005, 
Peretti and colleagues proposed to sub-classify cT2 tumors into five pT subcategories in 
relation to the size, site, and patterns of superficial and submucosal diffusion analyzed by 
clinical, radiologic, surgical and pathological examinations.15 They demonstrated that 
unimodal endoscopic laser resection provides a good oncological outcome in the majority 
of cT2; in contrast, tumors upstaged as pT3 for involvement of the PGS, represent a 
completely different disease, which negatively influences prognosis.15  
Based on these observations, we followed the staging policy and the sub-classification of 
cT2 proposed by Peretti and colleagues in a cohort of patients treated by OPHL, with the 
aim of emphasizing the role of OPHL in patients affected by T2 and selected T3, and 
comparing the oncological and functional outcomes with those obtained by TLM. 
Hence, a multicentric retrospective outcomes analysis of 216 patients with glottic laryngeal 
SCC classified as cT2 and managed by Type II–III OPHLs is presented. The analysis was 
conducted over a 16-year period during which TLM or radiotherapy were applied as 
alternative therapeutic options.6, 16 
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Material and methods 
 
Patients 
All patients were from the Hospital of Vittorio Veneto (Treviso) or the Martini Hospital of 
Turin (Italy). Selection was based on a routinely performed clinical assessment lasting 3 
weeks prior to surgery, in order to evaluate the superficial and depth extent of the tumor, 
as previously described.8 
Inclusion criteria were: histological diagnosis of glottic cT2 laryngeal SCC, with Karnofsky 
index higher than 80 (Table 1). Exclusion criteria were severe diabetes mellitus, severe 
bronchopulmonary chronic obstructive disease, neurological problems impairing the ability 
to expectorate and/or swallow, or severe cardiac disease. Advanced age, an important 
cut-off for relative surgical indication18, has not been considered, in itself, as an exclusion 
criterion.  
After informed consent had been obtained, 216 patients with glottic squamous cell 
carcinoma, classified as cT2 according to the 2002 TNM classification system,19 
underwent a modular function sparing surgical approach between 1 January 1995 and 31 
December 2011. Thirty-nine patients (18.1%) included in the present analysis had been 
treated previously for laryngeal carcinoma by TLM (20/39, 51.3%), radiation therapy (12/39, 
30.8%) or cordectomy (7/39, 17.9%).  
Vocal fold mobility assessment resulted in 71 cases with normal vocal cord mobility, and 
145 cases with impaired vocal cord mobility and mobile cricoarytenoid joint. 
All patients were submitted to neck computed tomography (CT) or magnetic resonance 
imaging (MRI) to rule out infiltration of the cartilaginous framework and evaluate the extent 
of the pre-epiglottic space and/or paraglottic space. 
The preoperative records, radiologic images as well as all surgical specimens were 
retrospectively reviewed to allow the reclassification of all cases, according to the 
Page 7 of 27
John Wiley & Sons, Inc.
Head & Neck
This article is protected by copyright. All rights reserved.
  
UICC/AJCC classification. Moreover, after the final histology, the entire cohort of cT2 were 
divided into five subtypes as suggested by Peretti and colleagues (Fig. 1).15 
 
Surgery 
Open neck procedures were classified according to the European Laryngological Society 
Classification: Type IIa (supracricoid partial laryngectomy/cricohyoidoepiglottopexy) = 
76/216 (35.2%), Type IIa + ARY = 102/216 (47.2%), Type IIb (supracricoid partial 
laryngectomy/cricohyoidopexy) = 12/216 (5.55%), Type IIb + ARY = 12/216 (5.55%), Type 
IIIa (supratracheal partial laryngectomy/tracheohyoidoepiglottopexy) = 1/216 (0.5%), Type 
IIIa + CAU = 13/216 (6.0%), where “+ARY” represents the removal of one arytenoid and 
“+CAU” the removal of one cricoarytenoid unit. 
The indications adopted for Type II OPHLs were the classical ones, applied according to 
tumor extent, now being accepted and advocated by numerous authors.5, 20-24 Although 
definitions for the Type III OPHLs were only recently introduced, the precise indications for 
tumors at the cT2 classification were lesions with anterior or lateral subglottic extension, 
spreading downward above the conus elasticus and reaching the cricoid ring. 
In all patients, resection margins were examined intraoperatively with frozen sections: 
when positive, the resection was expanded until the margins were negative. The margins 
of the surgical specimen were always checked again upon definitive pathology. The 
interventions were conducted using the principles of a modular approach. The resection is 
always prepared in standard mode and the larynx is opened from the side less affected by 
disease. At this point, under visual control, the subsites involved are removed and the 
resection can be enlarged as follows: (1) Type IIa/b  Type IIa/b + ARY; (2) Type IIIa  
Type IIIa + CAU; (3) Type IIa  Type IIb; (4) Type IIa + ARY  Type IIIa + CAU. 
Neck dissection (ND), graded according to the American Academy of Otolaryngology – 
Head and Neck Surgery Foundation classification, was performed in 204 patients (94.4%), 
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and was monolateral in 168/204 (82.4%) and bilateral in 36/204 (17.6%) cases. ND was 
elective (ND levels II–IV) in 198 cN0 patients (97.1%) and curative (ND levels II–V + 
Internal Jugular Vein in one case) in 6 cN>0 patients (2.9%). In nine patients, whole level 
VI or unilateral paratracheal lymph node clearance was added. No ND was performed in 
an additional 12/216 patients (5.55%, elderly and/or cN0 disease or in previously treated 
neck) (Table 1). 
 
Postoperative care  
All patients were monitored for early complications (local and general) and late sequelae. 
Patients underwent the same rehabilitation protocol, apart from those with serious early 
complications. The postoperative protocol was in accordance with our previous report. 
Briefly, this was: (1) insertion of an uncuffed tracheal cannula and beginning of phonation 
(days 1 to 4); (2) intermittent occlusion of the tracheostomy with saline-soaked gauze and 
starting of feeding without the tracheal cannula in position (days 4 to 6); (3) nasogastric 
(NG) tube removal as soon as a good level of swallowing of both solids and liquids was 
achieved (day 6 onwards). Postoperative aspiration was graded in accordance with 
Pearson’s Scale (0 = none; I = occasional cough but no clinical problems; II = constant 
cough worsening with meal or swallowing; III = pulmonary complications).26 
 
Adjuvant treatments 
On the basis of pathological findings (pN+ and/or extracapsular spread extension, positive 
margins), 9 patients (4.2%) were subjected to adjuvant radiotherapy. The indications for 
adjuvant therapy were: 5 N+ (1 pN1 and 4 pN2, all with extracapsular spread) and 4 cases 
with positive margins. 
A large volume encompassing the primary site and all draining lymph nodes was irradiated 
with a dose of up to 54 Gy/2 Gy. Regions at higher risk for malignant dissemination 
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received a 12-Gy boost (total 66 Gy/2 Gy – range 62–68 Gy). Six of 9 patients (5 pN+ with 
extracapsular spread, and 1 multiple positive margins toward cricoid) also received 100 
mg/m2 cisplatin on days 1, 22, and 43 of the course of radiotherapy.27 
 
Larynx oncologic and functional assessment 
All patients were followed for a mean period of 5.71 years with periodic videolaryngoscopic 
examinations, scheduled every 3 months in the first 3 years and with decreasing frequency 
in the subsequent period.  
During the 5 postoperative years, Pearson’s Scale evaluation was repeated and larynx 
functional status was evaluated with the Performance Status Scale.28 The latter is a simple, 
practical, clinician-rated assessment tool consisting of three subscales: speech 
comprehension, normalcy of diet and eating in public, graduated from 0 to 100 on the 
basis of predefined parameters. 
 
Statistical methods 
Overall survival (OS), disease-free survival (DFS), disease-specific survival (DSS), 
locoregional control (LRC), local control (LC), laryngectomy-free survival (LFS) and 
laryngeal function preservation (LFP), were assessed by means of Kaplan-Meier curves. 
Log-rank and Gehan-Breslow-Wilcoxon tests (for early events) were used to compare 
Kaplan-Meier estimates between groups (cT2 subtypes, clinical history of previous 
treatment, type of surgery, and age).  The end points considered were obtained as the 
length of time from the date of diagnosis to: OS) the date of death; DFS) the date of the 
first recurrence; DSS) the date of death from the disease; LRC) the date of the first 
locoregional recurrence; LC) the date of the first local recurrence; LFS) the date of total 
laryngectomy; LFP) the date of total laryngectomy or presence of tracheostomy, NG tube, 
gastrostomy feeding, or non-intelligible voice.  
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All analyses were performed with GraphPad Prism version 5.00 (GraphPad Software, San 
Diego, CA, USA), with p < 0.05 as the statistically significant cut-off. 
 
RESULTS 
 
Pathology, survival and disease control 
Comparison between clinical findings (CT-scan or MRI) and pathological staging proved 
up-staging on the primary tumor from cT2 to pT3 in 36 cases (16.7%). The review of 
radiologic images after the definite histology showed a suspect PGS involvement in only 
21 patients. Pathology reports indicated close margins (<2 mm) in 9/216 cases (4.2%) and 
positive margins in 4/216 cases (1.9%). Six patients (2.8%) developed recurrence between 
11 and 33 months. The recurrences were observed in 5 out of 180 pT2 (2.8%) and 1 out of 
36 pT3 (2.8%). 
In particular, in subtype I, no recurrences were observed. In subtype II, one local 
recurrence was observed among 13 patients. The patient was successfully treated by TLM 
and was free from recurrence at 46 months. In the subtype III, 3 out of 40 patients (7.5%) 
experienced local (1), regional (1), or locoregional (1) recurrences. Salvage therapy for 
local recurrence included total laryngectomy and adjuvant chemoradiation therapy. The 
first patient died of other disease 15 months later; the second patient showed a second 
recurrence 22 months later and died of the disease 8 months later, while the third is free of 
disease at 32 months. Among the patients with regional recurrence (neck), both were 
previously classified as pN0. At the time of primary resection, both received monolateral 
neck dissection. One recurrence was observed at the VI level. Recurrences in the neck 
were treated with surgery and radiation therapy; one patient died as a result of regional 
recurrences 22 months later, and one is alive and disease-free. In the subtype IV, 1 out of 
116 patients (0.9%) experienced both local and regional recurrences. The patient was 
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previously classified as pN0 and was treated with surgery, including total laryngectomy, 
and radiation therapy; the patient died as a result of distant metastases. In the subtype V 
(cT2/pT3), among 36 patients, there was 1 patient (previously classified as pN0) suffering 
from both local and regional recurrences (2.7%). Salvage therapy included total 
laryngectomy and adjuvant chemoradiation therapy, but the patient died of the disease 14 
months later. Overall, lymph node metastases were detected in 9/204 patients (4.4%), of 
whom 4 (2.0%) had multiple metastases. 
The 5-year OS, DSS, LRC and LC were 93.1%, 98.0%, 97.1%, and 97.5%, respectively 
(Fig. 2). A total of 13 patients had died: 4 of them for the laryngeal cancer and 9 from 
unrelated causes (Table 2). As DFS and LRC were overlapping in our patient cohort, we 
only reported LRC in our analyses. 
Although DSS prevalence 5 years after surgery was not affected by any of the variables 
analyzed, the history of previous treatment and the employment of more invasive surgery 
provided small but significant impairments in both local and regional control (the former 
also as an early event, p < 0.01, Gehan-Breslow-Wilcoxon test) (Fig. 3).  
 
Postoperative course and morbidity 
Overall acute complications during hospitalization occurred in 18 out 216 patients (8.3%) 
and there were no perioperative deaths. The mean hospitalization time for patients with 
acute complications was 29 ± 6 days, which was significantly longer than that for patients 
without acute complications (19 ± 4 days). Late sequelae following discharge were 
observed in 26 out of 216 cases (12.0%) (Table 3). All were successfully treated with TLM 
(8/10, 80%), and injective laryngoplasty using Vox-implants, which successfully treated 
dysphagia (2/10, 20%). 
 
Laryngeal function preservation 
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At 5 years after surgery, LFP was maintained in 97.8% of patients whereas the use of total 
laryngectomy was avoided in 98.5% (Fig. 4). In addition, we evaluated whether pT 
subtypes, previous treatment, age, and the type of surgery could affect LFP or even the 
use of total laryngectomy (Table 4). None of these variables were able to significantly 
affect the preservation of laryngeal function. Nevertheless, the history of previous 
treatment induced a slight but significant early enhancement in the number of total 
laryngectomies within the first 2 years after the OPHL (p < 0.05, Gehan-Breslow-Wilcoxon 
test). 
After the first post-operative month, normal swallowing (Pearson’s scale Grade 0) was 
achieved in 134 patients (62.0%), Grade I and II were observed in 43 (19.9%) and 35 
(16.2%) patients, respectively, while aspiration pneumonia (AP) (Pearson’s Grade III) was 
recorded in 4 patients (1.9%). After the second year, a satisfactory degree of laryngeal 
function (i.e. List’s scale: eating in public >50, understandability of speech >50, normalcy 
of diet >70)28 was achieved in 179 out of 211 patients without local disease (84.8%). Out 
of the 211 patients evaluated for subjective aspiration with the Pearson’s Scale,26 95 
(45.0%) had no aspiration (Grade 0), 94 (44.5%) had occasional cough without clinical 
problems (Grade I), 20 (9.5%) had constant cough that worsened during meals (Grade II), 
and 2 patients (0.9%) had frequent pulmonary complications (Grade III). All patients had 
the NG tube or gastrostomy removed. The NG tube remained in place for an average of 
18.5 days (range 9–130 days). 
Overall, AP was observed in 6/216 cases (2.8%), 4 cases during hospitalization and 2 
cases during follow-up. Completion of total laryngectomy for persistent aspiration was not 
required in any patient. Two patients were subjected to the endoscopic procedure of 
injective laryngoplasty using Vox implants, which successfully resolved the dysphagia. 
The mean time to intermittent occlusion of the tracheostomy was 22.6 days (range 5–166 
days), and the average time to tracheostomy closure was 71.4 days (range 21–198 days). 
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In our protocol, progressive closure of the tracheostomy is preferred, and occurs 
spontaneously in the majority of patients following occlusion. For patients, especially in the 
first weeks after discharge, this leads to a sensation of greater safety concerning minor 
episodes of food inhalation, which are relatively frequent. When the tracheostomy has 
almost closed, minor plastic surgery can then be performed. 
 
DISCUSSION 
In the early 1970s, by systematically applying whole organ sections in the study of total 
laryngectomy specimens, Kirchner, Oloffson and colleagues well described the patterns of 
spread of laryngeal cancer.30, 31 PGS invasion is a critical point of weakness, above all 
when the lesion reaches the base and roof of the ventricle: this constitutes the gateway for 
the tumor spreading toward the thyroarytenoid space and cricoarytenoid joint. These 
lesions, even though clinically defined as cT2, are actually pT3, showing a more 
aggressive behavior. 
According to the literature on transoral laser treatment for intermediate staged glottic 
cancer (T2/T3), TLM has shown a signicant increase of recurrences in those cases with 
involvement of PGS and impairment and/or fixation of the true vocal cords.13-15 In a study 
of 55 patients with glottic cT2, Peretti et al.15 concluded that TLM can be considered 
effective when the pT2 stage has been confirmed. By contrast, in cT2/pT3 patients, after 
the first transoral resection that allows the correct pT staging, additional treatment should 
always be considered. In a cohort of 167 patients treated by TLM, Ambrosch6 reported a 
local control rate of 74% and a laryngectomy rate of 13.4% in 97 patients staged pT2 while 
a 5-year local control rate of 68% and laryngectomy rate of 14.3% was observed in 70 
patients staged pT3. Canis et al. reported a retrospective study of 391 previously 
untreated patients affected by glottic cT2/T3: they noted a 93% larynx preservation rate 
among pT2a and 83% among pT2b and pT3 tumors.7  
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Preoperative under-staging, in the glottic cT2 category, occurs with some frequency 
because of misinterpretation of radiologic data among patients with suspected involvement 
of PGS; the lack of sensitivity on early PGS involvement is greater using CT-scan 
compared to MRI. 
Therefore, intermediate stage glottic cancer requires patients for TLM to be selected very 
carefully, reserving open neck surgery or non-surgical treatments for patients in whom an 
up-staging of the lesion is presumed. 
In our series, upstaging of cT2 to pT3 was found in specimens from 16.7% of cases, in 
whom early invasion of the PGS was not detected by imaging before the operation. The 
misdiagnosis of selected cT2 lacking the assessment of the PGS may possibly explain the 
gap in terms of local control between OPHLs and TLM as therapeutic options. 
Our data show that the outstanding oncological outcomes obtained by OPHL reproduced 
by other authors31,32 justify the open-neck procedures in terms of local control, particularly 
in selected pT3 lesions. In fact, in this cohort, any variables analyzed have shown a 
negative impact on the end points evaluated. 
In contrast, in some cases after OPHL, the functional outcomes in terms of complication 
rates and hospitalization times are negatively influenced. Persistent slight dysphagia and 
aspiration pneumonia still represent major complications in patients undergoing OPHLs, 
especially Type III, while voice is significantly deteriorated, and generally quite hoarse and 
breathy.20, 21, 23 Moreover, the functional outcome of OPHLs, especially for extended 
interventions (Type IIb, Type III), is generally associated with slower recovery and longer 
hospitalization compared to TLM.  
For this reason, despite the excellent oncological results, the surgeon faced with 
intermediate staged tumors must consider TLM as alternative for all pT2, especially in 
elderly and fragile patients not fit for OPHL. In the case of high risk lesions (subtype V  
cT2/pT3), TLM could play a role as a definitive staging procedure with outstanding 
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precision in microscopically detecting deep neoplastic invasion and consequently, possible 
patterns of cancer progression. 
When discussing conservative surgical options with the patient affected by a cT2 tumor 
with unimpaired mobility of vocal cords, he should be clearly informed that TLM is equally 
as safe as open neck surgery, with a more rapid recovery and with less impact on quality 
of life, even though further procedures, for example, re-resection and/or open neck surgery 
should be kept in mind in the case of upstaging to pT3. 
In conclusion, our results demonstrate that, in every case of glottic cT2, OPHL with a 
modular approach can be considered to be a very safe option. Bearing in mind that 
OPHLs lead to more dysfunctional sequelae compared to TLM, the open-neck options 
should essentially be aimed at carefully selected patients affected by glottic cT2 with 
impaired mobility of vocal cords and suspected extension to the PGS. 
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Figure legends 
Fig. 1. Graphical representation of T2 glottic carcinoma subtypes: (I) pT2 with superficial 
supraglottic extension to the base and roof of the ventricle and/or ventricular band; (II) pT2 
with superficial lateral subglottic extension; (III) pT2 with anterior supracommissural and/or 
subcommissural extension; (IV) pT2 with deep thyroarytenoid (TA) muscle infiltration; (V) 
pT3 for superior and/or inferior PGS invasion lateral to the thyroarytenoid muscle. 
 
Fig. 2. End point analysis (overall survival, disease-specific survival, locoregional control, 
and local control) of the patient cohort using Kaplan–Meier curves. 
 
Fig. 3. Patient cohort stratification for pT subtypes (first column), history of previous 
treatment (second column), age (third column), and type of surgery (fourth column) using 
Kaplan–Meier curves. The end points considered were (from top to bottom) disease-
specific survival, locoregional control, and local control. *p < 0.05; **p < 0.01. 
 
Fig. 4. End point analysis of laryngeal function preservation and laryngectomy-free survival 
in the patient cohort using Kaplan–Meier curves. 
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Figure1. Graphical representation of T2 glottic carcinoma subtypes: (I) pT2 with superficial supraglottic 
extension to the base and roof of the ventricle and/or ventricular band; (II) pT2 with superficial lateral 
subglottic extension; (III) pT2 with anterior supracommissural and/or subcommissural extension; (IV) pT2 
with deep thyroarytenoid (TA) muscle infiltration; (V) pT3 for superior and/or inferior PGS invasion lateral to 
the thyroarytenoid muscle.  
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Figure 2. End point analysis (overall survival, disease specific survival, locoregional control, and local 
control) of the patient cohort using Kaplan–Meier curves  
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Figure 3. Patient cohort stratification for pT subtypes (first column), history of previous treatment (second 
column), age (third column), and type of surgery (fourth column) using Kaplan–Meier curves. The end 
points considered were (from top to bottom) disease-specific survival, locoregional control, and local control. 
*p < 0.05; **p < 0.01.  
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Figure 4. End point analysis of laryngeal function preservation and laryngectomy-free survival in the patient 
cohort using Kaplan–Meier curves  
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 Table 1. Characteristics of the 216 patients undergoing open partial horizontal laryngectomies 
according to age, sex, Karnofsky performance status, pathological grade and pT sub-category 
 No. of Patients (%) 
Age, years  
Mean 59.8±9.9 
Range 23–87 
  
Sex  
Male 201/216 (93.1%) 
Female 15/216   (6.9%) 
  
Karnofsky Performance Status  
100 128/216 (59.3%) 
90 65/216 (30.1%) 
80 23/216 (10.6%) 
  
Pathological Grade  
pT2 180/216 (83.3%) 
pT3 36/216 (16.7%) 
  
pN0 195/204 (95.6%) 
pN1 5/204   (2.4%) 
pN2 4/204   (2.0%) 
  
Level VI pN+ 1/9 (11.1%) 
  
pT Sub-category  
I 11/216   (5.1%) 
II 13/216   (6.0%) 
III 40/216 (18.5%) 
IV 116/216 (53.7%) 
V 36/216 (16.7%) 
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Table 2: Cause of death 
 No. of Patients (%) 
Laryngeal cancer 4/216 (1.8%) 
Post-operative death 0/216 (0.0%) 
II Primary Cancer 4/216 (1.8%) 
Unrelated to laryngeal cancer 5/216 (2.3%) 
Total deaths 13/216 (6.0%) 
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Table 3. Acute postoperative complications and late sequelae 
 No. of patients (%) 
Acute complications  
Cervical bleeding 5/216   (2.3%) 
Aspiration pneumonia 4/216   (1.8%) 
Wound infection 5/216   (2.3%) 
Others 4/216   (1.8%) 
Late sequelae  
Laryngeal soft tissue stenosis 23/216 (10.6%) 
Aspiration pneumonia 2/216   (0.9%) 
Dyspnea 1/216   (0.5%) 
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Table 4. Five-years incidences and Kaplan-Meier estimates stratified LFP and LFS 
 No. of 
Patients 
LFP LFS 
 Incidence (%) Estimates Incidence (%) Estimates 
pT subtypes     
I 11/216 11/11  (100%) 100% 11/11  (100%) 100% 
II 13/216 13/13  (100%) 100% 13/13  (100%) 100% 
III 40/216 38/40 (95.0%) 93.8% 39/40 (97.5%) 97.4% 
IV 116/216 115/116 (99.1%) 99.1% 115/116 (99.1%) 99.1% 
V 36/216 35/36 (97.2%) 96.9% 35/36 (97.2%) 96.9% 
      
Previous treatment     
Untreated 177/216 175/177 (98.9%) 98.6% 176/177 (99.4%) 99.4% 
Treated 39/216 37/39 (94.9%) 94.6% 37/39 (94.9%) *  94.6% 
      
Age (years)     
<65 144/216 140/144 (97.2%) 94.7% 141/144 (97.9%) 100% 
≥65 72/216 72/72  (100%) 97.8% 72/72  (100%) 100% 
     
OPHL     
Type IIa 178/216 175/178 (98.3%) 98.0% 176/178 (98.9%) 98.8% 
Type IIb 24/216 23/24 (95.8%) 95.8% 23/24 (95.8%) 95.8% 
Type IIIa 14/216 14/14  (100%) 100% 14/14  (100%) 100% 
Log-Rank test. * = p < .05. 
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